Berkeley Capital Partners, LLC Bristol Myers Squibb CO Transaction History
Berkeley Capital Partners, LLC
- $409 Million
- Q3 2025
A detailed history of Berkeley Capital Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Berkeley Capital Partners, LLC holds 53,366 shares of BMY stock, worth $2.5 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
53,366
Previous 49,072
8.75%
Holding current value
$2.5 Million
Previous $2.27 Million
5.94%
% of portfolio
0.59%
Previous 0.6%
Shares
33 transactions
Others Institutions Holding BMY
# of Institutions
2,680Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...